Yasir B. Al-Wakeel
Chief Financial Officer, MERRIMACK PHARMACEUTICALS INC.
Companies
- MaxCyte (United States)Board member Jul 29, 2021 to now1
- Kronos Bio, Inc.Chief financial officer Oct 8, 2020 to Jul 7, 20232
- MERRIMACK PHARMACEUTICALS INCChief financial officer Aug 13, 2015 to Feb 10, 20163
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- MaxCyte (United States) MXCT80,998 shares4$105.3K at $1.30Jun 17, 2026
- Kronos Bio, Inc.346,102 shares5Jul 6, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 17, 2026Granted 30,421 shares of MaxCyte (United States)4
- Jun 18, 2025Granted 29,210 shares of MaxCyte (United States)6
- Jun 11, 2024Granted 21,367 shares of MaxCyte (United States)7
- Jul 6, 2023Sold 9,617 shares at $1.75 of Kronos Bio, Inc.5
- Feb 24, 2023Sold 9,026 shares at $1.74 of Kronos Bio, Inc.8
- Feb 15, 2023Granted 138,911 shares of Kronos Bio, Inc.9
- Jul 25, 2022Granted 53,600 shares of Kronos Bio, Inc.10
- Feb 15, 2022Granted 53,600 shares of Kronos Bio, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Jun 23, 2025
- 7SEC EDGARForm 4 filed Jun 13, 2024
- 8SEC EDGARForm 4 filed Feb 24, 2023
- 9SEC EDGARForm 4 filed Feb 17, 2023
- 10SEC EDGARForm 4 filed Jul 27, 2022
- 11SEC EDGARForm 4 filed Feb 17, 2022